BIO-key International, Inc. (NASDAQ:BKYI) is a prominent player in the Identity and Access Management sector, specializing in biometric authentication technologies. Despite its leadership position, the company reported an earnings per share (EPS) of -$0.19 on March 31, 2026, which was below the estimated EPS of -$0.07. This indicates a larger-than-expected loss per share for the quarter.
The company's revenue for the quarter was approximately $1.24 million, falling short of the estimated $2.2 million. However, BIO-key's financial results for the full year ending December 31, 2025, showed a revenue of $6.1 million. This suggests that while the quarterly performance was underwhelming, the company had a relatively stronger year overall.
BIO-key's cash position improved significantly, ending 2025 with $2.7 million compared to $400,000 in 2024. This improvement is crucial as it supports the company's expectations for strong growth in 2026. The preliminary results for the first quarter of 2026 show a revenue of $2.2 million, marking a 37% increase compared to the first quarter of 2025.
CEO Mike DePasquale emphasized the strategic transition to selling exclusively BIO-key branded solutions, which positions the company for continued success. Despite the quarterly net loss of about $1.72 million, the company remains optimistic about its future prospects. An investor call is scheduled to discuss these results further, providing stakeholders an opportunity to engage with the company's leadership.
